TMS Related Biomarker Assessments

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
University of Maryland, Baltimore
Study ID
NCT05660018
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • active rTMS first, then sham rTMS — DEVICE
    Active rTMS is delivered on the first visit, then sham rTMS is delivered on the second visit.
  • sham rTMS first, then active rTMS — DEVICE
    Sham rTMS is delivered on the first visit, then active rTMS is delivered on the second visit.

Study Details

Patients with schizophrenia spectrum disorder (SSD) will be exposed to active and sham repetitive transcranial magnetic stimulation (rTMS) in separate sessions. SSD-related biomarkers will be assessed before and after the rTMS administration.

Key Dates

Start date
Jan 7, 2023
Status verified
Dec 2025
Primary completion
Feb 14, 2025
Completion
Feb 14, 2025

Study Design

Enrollment
10 participants (actual)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER

Arms

  • Other: Active rTMS first and sham rTMS second
    Participants in this arm will receive active rTMS in one visit first, then receive sham rTMS in another visit.
  • Other: Sham rTMS first and active rTMS second
    Participants in this arm will receive sham rTMS in one visit first, then receive active rTMS in another visit.

Primary Outcome Measure

Change of Resting-state Functional Connectivity (rsFC) by Active and Sham rTMS [ Time Frame: 2 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Maryland, BaltimoreBaltimoreMaryland21228-

Find similar trials in Baltimore, MD

By condition
Schizophrenia
By specialty
PsychiatryMental healthBehavioral health
By research site
University of Maryland, Baltimore· Baltimore, MD

Related Studies